Technology Core

项目摘要/摘要-技术核心 心、肺、血液和睡眠护理技术进步中心(CAPCaT)的目标 障碍(HLBS)是开发和优化新的护理点技术(POC)和基于家庭的 改善HLBS疾病的诊断和治疗的技术，特别是针对低血压病的技术 资源设置。HLBS疾病共同代表了#年发病率和死亡率的单一最大来源 在美国，它们不成比例地影响到小型化和服务不足的人口。新的PoC和基于家庭的服务 技术是正在进行的医疗转型的关键推动因素，医疗转型正在从 专门的住院检测设施走进诊所和家庭。CAPCaT最初是基于高度 成功的医疗产品孵化器马萨诸塞州医疗器械开发中心(M2D2) 马萨诸塞大学洛厄尔分校和马萨诸塞大学陈分校。UMassLowell在以下方面具有优势 工程和商业，而伍斯特校区是陈大学医学院的所在地，第一所和 马萨诸塞州联邦唯一的公共学术卫生系统。在过去的五年里，CAPCaT 已经进行了四次全国性的申请征集，并从441名申请者中挑选、授予、监督、 并全面支持23项HLBS PoC创新。CAPCaT获奖者在 提供资金，改进/开发新产品，产生9项新知识产权，并带来新技术 投放市场。在这场竞争的更新中，CAPCaT的技术核心将继续发出广泛的 呼吁申请，并将选择和支持新的有功项目，重点放在后期PoC和家居- 来自HLBS领域的基于技术。遴选将基于以下方面的表现和潜力 临床影响、实施的可能性和解决HLBS健康差距的问题。CAPCaT的技术 CORE将利用马萨诸塞州洛厄尔大学和马萨诸塞州大学现有资源的强大集合，支持选定的项目 帮助进一步开发和改进后期原型，以达到验证和用户测试的目的。

Project Summary/Abstract – Technology Core The goal of the Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Disorders (HLBS) is to develop and optimize novel point of care technologies (POC) and home-based technologies to improve the diagnosis and treatment of HLBS disorders, especially those targeted for low resource settings. HLBS disorders collectively represent the single greatest source of morbidity and mortality in the US, and they disproportionately affect minoritized and underserved populations. New POC and home-based technologies are critical enablers of the ongoing transformation of healthcare, which is moving out from specialized inpatient testing facilities into the clinic and the home. CAPCaT was originally based on the highly successful medical product incubator, the Massachusetts Medical Device Development Center (M2D2), at the University of Massachusetts (UMass) Lowell and UMass Chan campuses. UMass Lowell has strengths in engineering and business, while the Worcester campus houses the UMass Chan Medical School, the first and only public academic health system in the Commonwealth of Massachusetts. Over the past five years, CAPCaT has conducted four national calls for applications and from 441 applicants has selected, awarded, monitored, and comprehensively supported 23 HLBS POC innovations. CAPCaT awardees have raised over $43M in funding, refined/developed new products, generated 9 new intellectual properties, and brought new technologies to market. In this competitive renewal, the Technology Core of CAPCaT will continue to issue broad-reaching calls for applications and will select and support new meritorious projects focusing on later-stage POC and home- based technologies from across the HLBS space. Selection will be based on performance and potential for clinical impact, likelihood of implementation and addressing an HLBS health disparity. CAPCaT’s Technology Core will support selected projects utilizing a strong collection of existing resources at UMass Lowell and UMass Chan to help further develop and refine later-stage prototypes to the point of validation and user-testing.